7632-10-2

Basic information

• Product Name: DL-Methamphetamine
• Synonyms: DL-Desoxyephedrine;(+-)-N,a-Dimethylbenzeneethanamine;(+-)-N,a-Dimethylphenethylamine;Benzeneethanamine, N,a-dimethyl- (9CI);dl-Methamphetamin;Ephedrine, deoxy-;N,a-Dimethylbenzeneethanamine;N,a-Dimethylphenethylamine
• CAS NO: 7632-10-2
• Molecular Formula: C₁₀H₁₅N
• Molecular Weight: 149.26
• EINECS: 231-559-0
• Mol File: 7632-10-2.mol
• Article Data: 22

Chemical Properties

• Melting Point: 134-135 °C
• Boiling Point: 260.33°C (rough estimate)
• Flash Point: 86.8°C
• Appearance: /
• Density: 0.9768 (rough estimate)
• Refractive Index: 1.5620 (estimate)
• Storage Temp.: -20°C
• PKA: 10.38±0.10(Predicted)
• CAS DataBase Reference: DL-Methamphetamine(CAS DataBase Reference)
• NIST Chemistry Reference: DL-Methamphetamine(7632-10-2)
• EPA Substance Registry System: DL-Methamphetamine(7632-10-2)

Safety Data

• RIDADR: UN1230 - class 3 - PG 2 - Methanol, solution
• WGK Germany: 1
• Hazardous Substances Data: 7632-10-2(Hazardous Substances Data)

Usage

InChI:InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3

Upstream product

• 19968-61-7 4-methyl-5-phenyl-1,3-thiazole 
• 141-52-6 sodium ethanolate 
• 29686-21-3 methyl-(1-methyl-2-phenyl-ethyliden)-amine 
• 6898-67-5 N-ethylidenemethylamine 
• 6921-34-2 benzylmagnesium chloride 
• 91485-48-2 3-Isopropyl-2-methyl-4--1-phenyl-3-pyrazolin-5-on 
• 102732-72-9 <5-(4-Methoxyphenyl)-2-furylmethyl>-methyl-(1-methyl-2-phenyl-ethyl)-amin 
• 52271-36-0 methamphetamine hydroxylamine 
• 6317-31-3 3,4-dimethyl-5-phenyl-2-oxo-1,3-oxazolidine 
• 134-71-4 rac-ephedrine hydrochloride 
• 50-00-0 formaldehyd 
• 60-15-1 2-amino-1-phenylpropane 
• 300-42-5 D-methamphetamine hydrochloride 
• 593-51-1 methylamine hydrochloride 

Downstream Products

• 537-46-2 Methamphetamin 
• 33817-09-3 (R)-2-methylamino-1-phenylpropane 
• 55901-99-0 2-chloro-N-methyl-N-(1-methyl-2-phenyl-ethyl)-acetamide 
• 90522-54-6 Heptafluorbutyryl-methylamphetamin 
• 90730-82-8 Isonicotinic acid N-methyl-β-phenylisopropylamide 
• 91485-50-6 2,3-Dimethyl-4--1-phenyl-3-pyrazolin-5-on 
• 537-46-2 (+)-N-methylamphetamine 
• 52271-36-0 methamphetamine hydroxylamine 
• 82485-46-9 N-aminomethyl desoxyephedrine 
• 147043-94-5 N-Carboxymethylmethamphetamin 
• 128013-74-1 3-[Methyl-(1-methyl-2-phenyl-ethyl)-amino]-propionic acid 
• 300-42-5 D-methamphetamine hydrochloride 
• 1207188-81-5 C₁₉H₂₄N₂O 
• 5632-43-9 (RS)-N-methyl-N-(2'-methoxybenzyl)-1-phenyl-propan-2-amine 

Relevant articles and documents

Compositions and Methods for Treating Cocaine, Nicotine, and Methamphetamine Dependence

This invention provides a composition of matter comprising a plurality of cocaine-succinyl-BSA, wherein the average ratio of cocaine-succinyl moieties to BSA is at least 7.0. This invention also provides a composition of matter comprising a plurality of nicotine-5-succinyl-BSA, wherein the average ratio of nicotine-5-succinyl moieties to BSA is at least 7.0. This invention further provides a composition of matter comprising a plurality of methamphetamine-5-succinyl-BSA, wherein the average ratio of methamphetamine-5-succinyl moieties to BSA is at least 7.0. This invention still further provides related pharmaceutical compositions, therapeutic methods, prophylactic methods, synthetic methods, and articles of manufacture.

Hydrogen activation by 2-boryl-N,N-dialkylanilines: A revision of Piers' ansa-aminoborane

Two 2-[bis(pentafluorophenyl)boryl]-N,N-dialkylanilines reported here exemplify a new class of intramolecular frustrated B/N Lewis pairs. A structure closely related to this class structure was synthesized in 2003 by Piers et al. but was unable to activate H2. The new aminoboranes can activate hydrogen at near ambient conditions; besides, one of them can hydrogenate imines and enamines in a catalytic fashion demonstrating the validity of the original Piers' approach to hydrogen activation with ansa-aminoboranes.

METHOD FOR MAKING PHARMACEUTICAL COMPOUNDS

A method of making a phenylethylamine of formula B: wherein R2, R3, R4, R5, R6, Rα, Rβ and Rn are each independently selected from hydrogen, alkyl, acyl, aryl, amido, amino acids, sugars and nucleotides. The method includes the reduction of a compound of formula A in the absence of base: wherein R2, R3, R4, R5, R6, Rα, Rβ and Rn are as defined above.